Predictors of health‐related quality of life in children and adolescents with juvenile idiopathic arthritis: Results from a web‐based survey
Lotte Haverman(Unknown), Marion A. J. van Rossum(Reade), Joost F. Swart(Trinity College Dublin), Taco W. Kuijpers(Sanquin), J. Merlijn van den Berg(Boston Children's Hospital), Mira van Veenendaal(Boston Children's Hospital), Koert M. Dolman(Reade), Martha A. Grootenhuis(University of Amsterdam)
Cited by 155
Related Papers
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
|Annals of the Rheumatic Diseases|2008|220
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
|Arthritis & Rheumatism|1998|217
Transforming Growth Factor-β Signaling Pathway in Patients With Kawasaki Disease
|Circulation Cardiovascular Genetics|2010|152